Wednesday , 21 February 2018

Home » RESOURCES » INVESTING » Juno buys Boston-based biotech RedoxTherapies

Juno buys Boston-based biotech RedoxTherapies

Juno Therapeutics Inc. on Thursday said it bought privately held, Boston-based RedoxTherapies, Inc. for an undisclosed amount, getting access to a RedoxTherapies’ blocker with potential to be used in certain cancer treatments. RedoxTherapies founder Michail Sitkovsky will become a scientific consultant to Juno, the company said. Shares of Juno rose 0.1% in late trading after ending the regular trading session down 5.2%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Juno buys Boston-based biotech RedoxTherapies Reviewed by on . Juno Therapeutics Inc. on Thursday said it bought privately held, Boston-based RedoxTherapies, Inc. for an undisclosed amount, getting access to a RedoxTherapie Juno Therapeutics Inc. on Thursday said it bought privately held, Boston-based RedoxTherapies, Inc. for an undisclosed amount, getting access to a RedoxTherapie Rating:
scroll to top